{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:49:20Z","timestamp":1787579360695,"version":"build-2736575974"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,4,24]],"date-time":"2014-04-24T00:00:00Z","timestamp":1398297600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s10143-014-0538-6","type":"journal-article","created":{"date-parts":[[2014,4,23]],"date-time":"2014-04-23T00:09:45Z","timestamp":1398211785000},"page":"381-388","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Treatment of epileptic seizures in brain tumors: a critical review"],"prefix":"10.1007","volume":"37","author":[{"given":"R.","family":"Bauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ortler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Seiz-Rosenhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. V.","family":"Anton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Unterberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,24]]},"reference":[{"key":"538_CR1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.seizure.2006.10.007","volume":"16","author":"M Al-Kaylani","year":"2007","unstructured":"Al-Kaylani M, Konrad P, Lazenby B et al (2007) Seizure freedom off antiepileptic drugs after temporal lobe epilepsy surgery. Seizure 16:95\u201398","journal-title":"Seizure"},{"key":"538_CR2","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3171\/jns.1997.87.2.0252","volume":"87","author":"GD Anderson","year":"1997","unstructured":"Anderson GD, Lin Y-X, Berge C, Ojemann GA (1997) Absence of bleeding complications in patients undergoing cortical surgery while receiving valproate treatment. J Neurosurg 87:251\u2013256","journal-title":"J Neurosurg"},{"key":"538_CR3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1023\/B:BRAT.0000006332.71345.b7","volume":"16","author":"JC Baayen","year":"2003","unstructured":"Baayen JC, de Jongh A, Stam CJ et al (2003) Localization of slow wave activity in patients with tumor-associated epilepsy. Brain Topogr 16:85\u201393","journal-title":"Brain Topogr"},{"key":"538_CR4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00701-011-1144-9","volume":"154","author":"O B\u00e4hr","year":"2012","unstructured":"B\u00e4hr O, Hermisson M, Rona S et al (2012) Intravenous and oral levetiracetam in patients with a suspected primary tumor and symptomatic seizures undergoing neurosurgery: the HELLO trial. Acta Neurochir 154:229\u2013235","journal-title":"Acta Neurochir"},{"key":"538_CR5","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/ana.20710","volume":"59","author":"F Bartolomei","year":"2006","unstructured":"Bartolomei F, Bosma I, Klein M et al (2006) How do brain tumors alter functional connectivity? A magnetoencephalography study. Ann Neurol 59:128\u2013138","journal-title":"Ann Neurol"},{"key":"538_CR6","unstructured":"Bauer G, Bauer R (2011) EEG, drug effects, and central nervous system poisoning. In: Schomer DL, Lopes da Silva F (eds.): Niedermeyer\u2019s electroencephalography, 6th ed. Wolters Kluwer\/Lippincott Williams & Wilkins, Philadelphia, Baltimore, New York, London, Buenos Aires, Hong Kong, Sydney, Tokyo, pp 901\u2013922"},{"key":"538_CR7","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s00701-007-1366-z","volume":"149","author":"R Bauer","year":"2007","unstructured":"Bauer R, Dobesberger J, Unterhofer C et al (2007) Outcome of adult patients with temporal lobe tumours and medically refractory focal epilepsy. Acta Neurochir 149:1211\u20131216","journal-title":"Acta Neurochir"},{"key":"538_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s007010050001","volume":"142","author":"A Beaumont","year":"2000","unstructured":"Beaumont A, Whittle IR (2000) The pathogenesis of tumour associated epilepsy. Acta Neurochir 142:1\u201315","journal-title":"Acta Neurochir"},{"key":"538_CR9","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1528-1167.2006.00371.x","volume":"47","author":"AT Berg","year":"2006","unstructured":"Berg AT, Vickrey BG, Langfitt JT et al (2006) Reduction of AEDs in postsurgical patients who attain remission. Epilepsia 47:64\u201371","journal-title":"Epilepsia"},{"key":"538_CR10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1528-1167.2009.02299.x","volume":"51","author":"S Beyenburg","year":"2010","unstructured":"Beyenburg S, Stavem K, Schmidt D (2010) Placebo-corrected efficacy of modern antiepileptic drugs for refractory epilepsy: systematic review and meta-analysis. Epilepsia 51:7\u201326","journal-title":"Epilepsia"},{"key":"538_CR11","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/med.20027","volume":"25","author":"RA Blaheta","year":"2005","unstructured":"Blaheta RA, Michaelis M, Hern\u00e1iz Driever P, Cinatl J (2005) Evolving anticancer drug valproic acid: Insights into mechanism and clinical studies. Med Res Rev 25:383\u2013397","journal-title":"Med Res Rev"},{"key":"538_CR12","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1227\/00006123-198503000-00002","volume":"16","author":"DJ Boarini","year":"1985","unstructured":"Boarini DJ, Beck DW, VanGilder JC (1985) Postoperative prophylactic anticonvulsant therapy in cerebral gliomas. Neurosurgery 16:290\u2013292","journal-title":"Neurosurgery"},{"key":"538_CR13","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1093\/neuonc\/noq044","volume":"12","author":"GC Bobustuc","year":"2010","unstructured":"Bobustuc GC, Baker CH, Limaye A et al (2010) Levetiracetam enhances p53-mediated MGMT inhibition and sensitizes glioblastoma cells to temozolomide. Neuro-Oncology 12:917\u2013927","journal-title":"Neuro-Oncology"},{"key":"538_CR14","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1528-1157.1991.tb04679.x","volume":"32","author":"PA Boon","year":"1991","unstructured":"Boon PA, Williamson PD, Fried I et al (1991) Intracranial, intraaxial, space-occupying lesions in patients with intractable partial seizures: an anatomoclinical, neuropsychological, and surgical correlation. Epilepsia 32:467\u2013476","journal-title":"Epilepsia"},{"key":"538_CR15","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1001\/archneur.63.12.1746","volume":"63","author":"R Cavaliere","year":"2006","unstructured":"Cavaliere R, Farace E, Schiff D (2006) Clinical implications of status epilepticus in patients with neoplasms. Arch Neurol 63:1746\u20131749","journal-title":"Arch Neurol"},{"key":"538_CR16","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3171\/2009.2.JNS081132","volume":"111","author":"KL Chaichana","year":"2009","unstructured":"Chaichana KL, Parker SL, Olivi A, Quinones-Hinojosa A (2009) Long-term seizure outcomes in adult patients undergoing primary resection of malignant brain astrocytomas. J Neurosurg 111:282\u2013292","journal-title":"J Neurosurg"},{"key":"538_CR17","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/jama.293.5.557","volume":"293","author":"SM Chang","year":"2005","unstructured":"Chang SM, Parney IF, Huang W et al (2005) Patterns of care for adults with newly diagnosed malignant glioma. JAMA 293:557\u2013564","journal-title":"JAMA"},{"key":"538_CR18","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3171\/JNS\/2008\/108\/2\/0227","volume":"108","author":"EF Chang","year":"2008","unstructured":"Chang EF, Potts MB, Keles GE et al (2008) Seizure characteristics and control following resection in 332 patients with low-grade gliomas. J Neurosurg 108:227\u2013235","journal-title":"J Neurosurg"},{"key":"538_CR19","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1212\/WNL.0b013e31826e9aa9","volume":"79","author":"F Chassoux","year":"2012","unstructured":"Chassoux F, Rodrigo S, Mellerio C et al (2012) Dysembryoplastic neuroepithelial tumors: an MRI-based scheme for epilepsy surgery. Neurology 79:1699\u20131707","journal-title":"Neurology"},{"key":"538_CR20","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3171\/jns.1996.84.3.0382","volume":"84","author":"BS Chozik","year":"1996","unstructured":"Chozik BS, Reinert S, Greenblatt SH (1996) Incidence of seizures after surgery for supratentorial meningiomas: a modern analysis. J Neurosurg 84:382\u2013386","journal-title":"J Neurosurg"},{"key":"538_CR21","first-page":"793","volume-title":"Epilepsy surgery","author":"GR Cosgrove","year":"2001","unstructured":"Cosgrove GR (2001) Epilepsy surgery for tumors, vascular malformations, trauma, and cerebrovascular disease. In: L\u00fcders HO, Comair YG (eds) Epilepsy surgery, 2nd edn. Lippincott, Philadelphia, pp 793\u2013799","edition":"2"},{"key":"538_CR22","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1212\/WNL.0b013e318228c110","volume":"77","author":"M Groot De","year":"2011","unstructured":"De Groot M, Aronica E, Heimans JJ, Reijneveld JC (2011) Synaptic vesicle protein 2A predicts response to levetiracetam in patients with glioma. Neurology 77:532\u2013539","journal-title":"Neurology"},{"key":"538_CR23","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1093\/brain\/awr310","volume":"135","author":"M Groot De","year":"2012","unstructured":"De Groot M, Reijneveld JC, Aronica E, Heimans JJ (2012) Epilepsy in patients with a brain tumour: focal epilepsy requires focused treatment. Brain 135:1002\u20131016","journal-title":"Brain"},{"key":"538_CR24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1528-1157.2002.24801.x","volume":"43","author":"A Santis De","year":"2002","unstructured":"De Santis A, Villani R, Sinisi M et al (2002) Add-on phenytoin fails to prevent early seizures after surgery for supratentorial brain tumors: a randomized controlled study. Epilepsia 43:175\u2013182","journal-title":"Epilepsia"},{"key":"538_CR25","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3171\/2011.3.JNS1153","volume":"115","author":"DJ Englot","year":"2011","unstructured":"Englot DJ, Berger MS, Barbaro NM, Chang EF (2011) Predictors of seizure freedom after resection of supratentorial low-grade gliomas. J Neurosurg 115:240\u2013244","journal-title":"J Neurosurg"},{"key":"538_CR26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1528-1167.2011.03269.x","volume":"253","author":"DJ Englot","year":"2012","unstructured":"Englot DJ, Berger MS, Barbaro NM, Chang EF (2012) Factors associated with seizure freedom in the surgical resection of glioneuronal tumors. Epilepsia 253:51\u201357","journal-title":"Epilepsia"},{"key":"538_CR27","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.0013-9580.2004.00104.x","volume":"45","author":"S Eyal","year":"2004","unstructured":"Eyal S, Yagen B, Sobol E et al (2004) The activity of antiepileptic drugs as histone deacetylase inhibitors. Epilepsia 45:737\u2013744","journal-title":"Epilepsia"},{"key":"538_CR28","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/j.1528-1167.2006.00619.x","volume":"47","author":"CH Ferrier","year":"2006","unstructured":"Ferrier CH, Aronica E, Leijten FSS et al (2006) Electrographic discharge patterns in glioneural tumors and focal cortical dysplasia. Epilepsia 47:1477\u20131486","journal-title":"Epilepsia"},{"key":"538_CR29","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1017\/S0317167100053361","volume":"30","author":"PA Forsyth","year":"2003","unstructured":"Forsyth PA, Weaver S, Fulton D et al (2003) Prophylactic anticonvulsants in patients with brain tumour. Can J Neurol Sci 30:106\u2013112","journal-title":"Can J Neurol Sci"},{"key":"538_CR30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF01420191","volume":"103","author":"S Franceschetti","year":"1990","unstructured":"Franceschetti S, Binelli S, Casazza M et al (1990) Influence of surgery and antiepileptic drugs on seizures symptomatic of cerebral tumors. Acta Neurochir 103:47\u201351","journal-title":"Acta Neurochir"},{"key":"538_CR31","first-page":"837","volume-title":"Antiepileptic drugs","author":"P Genton","year":"2002","unstructured":"Genton P, Gelisse P (2002) Valproic acid. Adverse effects. In: Levy RH, Mattson RH, Meldrum BS, Perucca E (eds) Antiepileptic drugs, 5th edn. Lippincott, Philadelphia, pp 837\u2013851","edition":"5"},{"key":"538_CR32","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1212\/WNL.54.10.1886","volume":"54","author":"MJ Glantz","year":"2000","unstructured":"Glantz MJ, Cole BF, Forsyth PA et al (2000) Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 54:1886\u20131894","journal-title":"Neurology"},{"key":"538_CR33","first-page":"15","volume":"33","author":"S Goldring","year":"1986","unstructured":"Goldring S, Rich KM, Picker S (1986) Experience with gliomas in patients presenting with a chronic seizure disorder. Clin Neurosurg 33:15\u201342","journal-title":"Clin Neurosurg"},{"key":"538_CR34","unstructured":"Hartman AL, Lesser RP (2011) Brain tumors and other space-occupying lesions. In: Schomer DL, Lopes da Silva F (eds.): Niedermeyer\u2019s electroencephalography, 6th ed. Wolters Kluwer\/Lippincott Williams & Wilkins, Philadelphia, Baltimore, New York, London, Buenos Aires, Hong Kong, Sydney, Tokyo, pp 321\u2013330"},{"key":"538_CR35","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/j.1528-1167.2008.01945.x","volume":"50","author":"DC Hesdorffer","year":"2009","unstructured":"Hesdorffer DC, Benn EKT, Cascino GD, Hauser WA (2009) Is a first acute symptomatic seizure epilepsy? Mortality and risk for recurrent seizure. Epilepsia 50:1102\u20131108","journal-title":"Epilepsia"},{"key":"538_CR36","doi-asserted-by":"crossref","unstructured":"Hess R (1970) Die epileptogenen Hirntumoren. In: Niedermeyer E (ed.): Epilepsy. Mod Probl Pharmacopsychiat. 1970;4: pp 200\u2013231","DOI":"10.1159\/000387365"},{"key":"538_CR37","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00701-004-0266-8","volume":"146","author":"S-L Hwang","year":"2004","unstructured":"Hwang S-L, Lin C-L, Lee K-S et al (2004) Factors influencing seizures in adult patients with supratentorial astrocytic tumors. Acta Neurochir 146:589\u2013594","journal-title":"Acta Neurochir"},{"key":"538_CR38","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000028946","volume":"32","author":"A Ianelli","year":"2000","unstructured":"Ianelli A, Guzzetta F, Battaglia D et al (2000) Surgical treatment of temporal tumors associated with epilepsy in children. Pediatr Neurosurg 32:248\u2013254","journal-title":"Pediatr Neurosurg"},{"key":"538_CR39","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1212\/WNL.0b013e3181bbfeca","volume":"73","author":"KA Jaeckle","year":"2009","unstructured":"Jaeckle KA, Ballman K, Furth A, Buckner JC (2009) Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma. Neurology 73:1207\u20131213","journal-title":"Neurology"},{"key":"538_CR40","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.seizure.2012.05.014","volume":"21","author":"CA Khalenberg","year":"2012","unstructured":"Khalenberg CA, Fadul CE, Roberts DW et al (2012) Seizure prognosis of patients with low-grade tumors. Seizure 21:540\u2013545","journal-title":"Seizure"},{"key":"538_CR41","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1001\/archneurol.2009.100","volume":"66","author":"RD Kilbride","year":"2009","unstructured":"Kilbride RD, Costello DJ, Chiappa KH (2009) How seizure detection by continuous electroencephalographic monitoring affects the prescribing of antiepileptic medications. Arch Neurol 66:723\u2013728","journal-title":"Arch Neurol"},{"key":"538_CR42","doi-asserted-by":"crossref","first-page":"114","DOI":"10.18773\/austprescr.2004.096","volume":"27","author":"CJ Kilpatrick","year":"2004","unstructured":"Kilpatrick CJ (2004) Withdrawal of antiepileptic drugs in seizure-free adults. Aust Prescr 27:114\u2013117","journal-title":"Aust Prescr"},{"key":"538_CR43","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.0013-9580.2005.28004.x","volume":"46","author":"YD Kim","year":"2005","unstructured":"Kim YD, Heo K, Park SC et al (2005) Antiepileptic drug withdrawal after successful surgery for intractable temporal lobe epilepsy. Epilepsia 46:251\u2013257","journal-title":"Epilepsia"},{"key":"538_CR44","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/ana.10712","volume":"54","author":"M Klein","year":"2003","unstructured":"Klein M, Engelberts NHJ, van der Ploeg HM et al (2003) Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life. Ann Neurol 54:514\u2013520","journal-title":"Ann Neurol"},{"key":"538_CR45","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1227\/00006123-198301000-00003","volume":"12","author":"DA Kvuam","year":"1983","unstructured":"Kvuam DA, Loftus CM, Copeland B, Quest DO (1983) Seizures during the immediate postoperative period. Neurosurgery 12:14\u201317","journal-title":"Neurosurgery"},{"key":"538_CR46","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.seizure.2007.05.014","volume":"17","author":"S-Y Lee","year":"2008","unstructured":"Lee S-Y, Lee J-Y, Kim DW et al (2008) Factors related to successful antiepileptic drug withdrawal after anterior temporal lobectomy for medial temporal lobe epilepsy. Seizure 17:11\u201318","journal-title":"Seizure"},{"key":"538_CR47","first-page":"336","volume":"67","author":"JW Lee","year":"2010","unstructured":"Lee JW, Wen PY, Hurwitz S et al (2010) Morphological characteristics of brain tumors causing seizures. Arch Neurol 67:336\u2013342","journal-title":"Arch Neurol"},{"key":"538_CR48","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0090-3019(89)90067-0","volume":"31","author":"S-T Lee","year":"1989","unstructured":"Lee S-T, Lui T-N, Chang C-N et al (1989) Prophylactic anticonvulsants for prevention of immediate and early postcraniotomy seizures. Surg Neurol 31:361\u2013364","journal-title":"Surg Neurol"},{"key":"538_CR49","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0920-1211(99)00066-2","volume":"38","author":"A-S Lieu","year":"2000","unstructured":"Lieu A-S, Howng S-L (2000) Intracranial meningiomas and epilepsy: incidence, prognosis and influencing factors. Epilepsy Res 38:45\u201352","journal-title":"Epilepsy Res"},{"key":"538_CR50","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000052089","volume":"45","author":"A Liigant","year":"2001","unstructured":"Liigant A, Haldre S, \u00d6un A et al (2001) Seizure disorders in patients with brain tumors. Eur Neurol 45:46\u201351","journal-title":"Eur Neurol"},{"key":"538_CR51","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s11060-008-9781-4","volume":"93","author":"DA Lim","year":"2009","unstructured":"Lim DA, Tarapore P, Chang E et al (2009) Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study. J Neurooncol 93:349\u2013354","journal-title":"J Neurooncol"},{"key":"538_CR52","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1528-1167.2007.01323.x","volume":"49","author":"MI Lossius","year":"2008","unstructured":"Lossius MI, Hessen E, Mohwinckel P et al (2008) Consequences of antiepileptic drug withdrawal: a randomized, double-blind study (Akershus Study). Epilepsia 49:455\u2013463","journal-title":"Epilepsia"},{"key":"538_CR53","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0959-8049(97)00374-2","volume":"34","author":"K Lote","year":"1998","unstructured":"Lote K, Stenwig AE, Skullerud K, Hirschberg H (1998) Prevalence and prognostic significance of epilepsy in patients with gliomas. Eur J Cancer 34:98\u2013102","journal-title":"Eur J Cancer"},{"key":"538_CR54","unstructured":"Lund M (1952) Epilepsy in association with intracranial tumour. Acta psychiat (Kbh) Suppl 81"},{"key":"538_CR55","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1046\/j.1528-1157.2003.56102.x","volume":"44","author":"C Luyken","year":"2003","unstructured":"Luyken C, Bl\u00fcmcke I, Fimmers R et al (2003) The spectrum of long-term epilepsy-associated tumors: long-term seizure outcome and tumor outcome and neurosurgical aspects. Epilepsia 44:822\u2013830","journal-title":"Epilepsia"},{"key":"538_CR56","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s11060-009-9977-2","volume":"96","author":"S Lwu","year":"2010","unstructured":"Lwu S, Hamilton MG, Forsyth PA et al (2010) Use of peri-operative anti-epileptic drugs in patients with newly diagnosed high grade malignant glioma: a single center experience. J Neurooncol 96:403\u2013408","journal-title":"J Neurooncol"},{"key":"538_CR57","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.clineuro.2007.05.017","volume":"109","author":"LM Lynam","year":"2007","unstructured":"Lynam LM, Lyons MK, Drazkowski JF et al (2007) Frequency of seizures in patients with newly diagnosed brain tumors: a retrospective review. Clin Neurol Neurosurg 109:634\u2013638","journal-title":"Clin Neurol Neurosurg"},{"key":"538_CR58","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11060-006-9162-9","volume":"80","author":"M Maschio","year":"2006","unstructured":"Maschio M, Albani F, Baruzzi A et al (2006) Levetiracetam therapy in patients with brain tumour and epilepsy. Neurooncol 80:97\u2013100","journal-title":"Neurooncol"},{"key":"538_CR59","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1007\/s00415-011-6132-8","volume":"258","author":"M Maschio","year":"2011","unstructured":"Maschio M, Dinapoli L, Mingoia M et al (2011) Lacosamide as add-on in brain tumor-related epilepsy. J Neurol 258:2100\u20132104","journal-title":"J Neurol"},{"key":"538_CR60","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1756-9966-28-60","volume":"28","author":"M Maschio","year":"2009","unstructured":"Maschio M, Dinapoli L, Vidiri L et al (2009) The role side effects play in the choice of antiepileptic therapy in brain tumor-related epilepsy: a comparative study on traditional antiepileptic drugs versus oxcarbazepine. J Exp Clin Cancer Res 28:60\u201366","journal-title":"J Exp Clin Cancer Res"},{"key":"538_CR61","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11060-007-9430-3","volume":"86","author":"M Maschio","year":"2008","unstructured":"Maschio M, Dinapoli L, Zarabla A et al (2008) Outcome and tolerability of topiramate in brain tumor associated epilepsy. J Neurooncol 86:61\u201370","journal-title":"J Neurooncol"},{"key":"538_CR62","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1017\/S0317167100022757","volume":"7","author":"E Matthew","year":"1980","unstructured":"Matthew E, Sherwin AL, Welner SA et al (1980) Seizures following intracranial surgery: incidence in the first post-operative week. Can J Neurol Sci 7:285\u2013290","journal-title":"Can J Neurol Sci"},{"key":"538_CR63","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11060-006-9229-7","volume":"81","author":"AM Mauro","year":"2007","unstructured":"Mauro AM, Bomprezzi C, Morresi S et al (2007) Prevention of early postoperative seizures in patients with primary brain tumors: preliminary experience with oxcarbazepine. J Neurooncol 81:279\u2013285","journal-title":"J Neurooncol"},{"key":"538_CR64","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1212\/WNL.0b013e3182644f7d","volume":"79","author":"R Menon","year":"2012","unstructured":"Menon R, Rathore C, Sarma S, Radhakrishan K (2012) Feasibility of antiepileptic drug withdrawal following extratemporal respective epilepsy surgery. Neurology 79:770\u2013776","journal-title":"Neurology"},{"key":"538_CR65","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.3171\/2010.5.JNS091367","volume":"113","author":"RT Merrell","year":"2010","unstructured":"Merrell RT, Anderson K, Meyer FB, Lachance DH (2010) Seizures in patients with glioma treated with phenytoin and levetiracetam. J Neurosurg 113:1176\u20131181","journal-title":"J Neurosurg"},{"key":"538_CR66","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.2174\/138161207782360528","volume":"13","author":"M Michaelis","year":"2007","unstructured":"Michaelis M, Doerr HW, Cinatl J (2007) Valproic acid as anti-cancer drug. Curr Pharm Des 13:3378\u20133393","journal-title":"Curr Pharm Des"},{"key":"538_CR67","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1212\/01.wnl.0000324624.52935.46","volume":"71","author":"TA Milligan","year":"2008","unstructured":"Milligan TA, Hurwitz S, Bromfield EB (2008) Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery. Neurology 71:665\u2013669","journal-title":"Neurology"},{"key":"538_CR68","first-page":"967","volume-title":"Epilepsy surgery","author":"HH Morris III","year":"2001","unstructured":"Morris HH III (2001) Lesionectomy as a treatment for chronic epilepsies: is it sufficient for a good outcome? In: L\u00fcders HO, Comair YG (eds) Epilepsy surgery, 2nd edn. Lippincott, Philadelphia, pp 967\u2013971","edition":"2"},{"key":"538_CR69","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/j.1528-1157.1993.tb02131.x","volume":"34","author":"HH Morris","year":"1993","unstructured":"Morris HH, Estes ML, Gilmore R et al (1993) Chronic intractable epilepsy as the only symptom of primary brain tumor. Epilepsia 34:1038\u20131043","journal-title":"Epilepsia"},{"key":"538_CR70","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11060-005-9070-4","volume":"78","author":"HB Newton","year":"2006","unstructured":"Newton HB, Goldlust SA, Pearl D (2006) Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients. J Neuro-Oncol 78:99\u2013102","journal-title":"J Neuro-Oncol"},{"key":"538_CR71","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.clineuro.2008.09.009","volume":"111","author":"J Novy","year":"2009","unstructured":"Novy J, Stupp R, Rossetti AO (2009) Pregabalin in patients with primary brain tumors and seizures: a preliminary observation. Clin Neurol Neurosurg 111:171\u2013173","journal-title":"Clin Neurol Neurosurg"},{"key":"538_CR72","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11060-004-2338-2","volume":"72","author":"S Oberndorfer","year":"2005","unstructured":"Oberndorfer S, Piribauer M, Marosi C et al (2005) P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy. J Neuro-Oncol 72:255\u2013260","journal-title":"J Neuro-Oncol"},{"key":"538_CR73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clineuro.2012.07.002","volume":"115","author":"C Pedersen","year":"2013","unstructured":"Pedersen C, Romner B (2013) Current treatment of low grade astrocytoma: a review. Clin Neurol Neurosurg 115:1\u20138","journal-title":"Clin Neurol Neurosurg"},{"key":"538_CR74","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0896-6974(05)80081-7","volume":"6","author":"C Raganathan","year":"1993","unstructured":"Raganathan C, Verma NP, Diaz FG (1993) Valproate and epilepsy surgery. J Epilepsy 6:142\u2013144","journal-title":"J Epilepsy"},{"key":"538_CR75","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1528-1167.2010.02890.x","volume":"52","author":"C Rathore","year":"2011","unstructured":"Rathore C, Panda S, Sarma PS, Radhakrishnan K (2011) How safe is it to withdraw antiepileptic drugs following successful surgery for mesial temporal lobe epilepsy? Epilepsia 52:627\u2013635","journal-title":"Epilepsia"},{"key":"538_CR76","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1007\/s10072-005-0404-y","volume":"26","author":"M Riva","year":"2005","unstructured":"Riva M (2005) Brain tumoral epilepsy: a review. Neurol Sci 26:S40\u2013S42","journal-title":"Neurol Sci"},{"key":"538_CR77","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/archneurol.2009.335","volume":"67","author":"A Rosati","year":"2010","unstructured":"Rosati A, Buttolo L, Stefini R et al (2010) Efficacy and safety of levetiracetam in patients with glioma. Arch Neurol 67:343\u2013346","journal-title":"Arch Neurol"},{"key":"538_CR78","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1212\/WNL.0b013e3181d8a5ed","volume":"74","author":"A Rossetti","year":"2010","unstructured":"Rossetti A, Stupp R (2010) Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioma. Neurology 74:1329","journal-title":"Neurology"},{"key":"538_CR79","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1046\/j.1528-1157.2003.05203.x","volume":"44","author":"B Schaller","year":"2003","unstructured":"Schaller B, R\u00fcegg S (2003) Brain tumor and seizures: pathophysiology and its implications for treatment revisited. Epilepsia 44:1223\u20131232","journal-title":"Epilepsia"},{"key":"538_CR80","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1212\/WNL.54.2.346","volume":"54","author":"Y Schiller","year":"2000","unstructured":"Schiller Y, Cascino GD, So EL et al (2000) Discontinuation of antiepileptic drugs after successful epilepsy surgery. Neurology 54:346\u2013349","journal-title":"Neurology"},{"key":"538_CR81","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s10143-009-0191-7","volume":"32","author":"MF Shamij","year":"2009","unstructured":"Shamij MF, Fric-Shamij EC, Benoit BG (2009) Brain tumors and epilepsy: pathophysiology of peritumoral changes. Neurosurg Rev 32:275\u2013285","journal-title":"Neurosurg Rev"},{"key":"538_CR82","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.3171\/2010.12.JNS101602","volume":"114","author":"JH Sherman","year":"2011","unstructured":"Sherman JH, Moldovan K, Yeoh HK et al (2011) Impact of temozolomide chemotherapy on seizure frequency in patients with low-grade gliomas. J Neurosurg 114:1617\u20131621","journal-title":"J Neurosurg"},{"key":"538_CR83","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3171\/2010.5.JNS091972","volume":"114","author":"ME Shughrue","year":"2011","unstructured":"Shughrue ME, Rutkowski MJ, Chang EF et al (2011) Postoperative seizures following the resection of convexity meningiomas: are prophylactic anticonvulsants indicated? J Neurosurg 114:705\u2013709","journal-title":"J Neurosurg"},{"key":"538_CR84","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11060-004-6912-4","volume":"74","author":"V Siomin","year":"2005","unstructured":"Siomin V, Angelov L, Li L, Vogelbaum MA (2005) Results of a survey of neurosurgical practice patterns regarding the prophylactic use of anti-epilepsy drugs in patients with brain tumors. J Neuro-Oncol 74:211\u2013215","journal-title":"J Neuro-Oncol"},{"key":"538_CR85","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.4065\/79.12.1489","volume":"79","author":"JI Sirven","year":"2004","unstructured":"Sirven JI, Wingerchuk DM, Drazkowski JF et al (2004) Seizure prophylaxis in patients with brain tumors: a meta-analysis. Mayo Clin Proc 79:1489\u20131494","journal-title":"Mayo Clin Proc"},{"key":"538_CR86","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0920-1211(02)00005-0","volume":"49","author":"S Striano","year":"2002","unstructured":"Striano S, Striano P, Bocella P et al (2002) Tiagabine in glial tumors. Epileps Res 49:81\u201385","journal-title":"Epileps Res"},{"key":"538_CR87","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJM199008233230801","volume":"323","author":"NR Temkin","year":"1990","unstructured":"Temkin NR, Dikmen SS, Wilensky AJ et al (1990) A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures. NEJM 323:497\u2013502","journal-title":"NEJM"},{"key":"538_CR88","first-page":"CD004424","volume":"18","author":"W Tremont-Lukats","year":"2008","unstructured":"Tremont-Lukats W, Ratilal BO, Armstrong T, Gilbert MR (2008) Antiepileptic drugs for preventing seizures in people with brain tumors. Cochrane Database Syst Rev 18:CD004424","journal-title":"Cochrane Database Syst Rev"},{"key":"538_CR89","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s00415-009-5156-9","volume":"256","author":"MSM Breemen Van","year":"2009","unstructured":"Van Breemen MSM, Rijsman RM, Taphoorn MJB et al (2009) Efficacy of anti-epileptic drugs in patients with gliomas and seizures. J Neurol 256:1519\u20131526","journal-title":"J Neurol"},{"key":"538_CR90","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1474-4422(07)70103-5","volume":"6","author":"MSM Breemen Van","year":"2007","unstructured":"Van Breemen MSM, Wilms EB, Vecht CJ (2007) Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurol 6:421\u2013430","journal-title":"Lancet Neurol"},{"issue":"Suppl 4","key":"538_CR91","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1212\/WNL.67.12_suppl_4.S10","volume":"67","author":"CJ Vecht","year":"2006","unstructured":"Vecht CJ, van Breemen MSM (2006) Optimizing therapy of seizures in patients with brain tumors. Neurology 67(Suppl 4):S10\u2013S13","journal-title":"Neurology"},{"key":"538_CR92","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S1474-4422(03)00435-6","volume":"2","author":"CJ Vecht","year":"2003","unstructured":"Vecht CJ, Wagner LG, Wilms EB (2003) Interactions between antiepileptic and chemotherapeutic drugs. Lancet Neurol 2:404\u2013409","journal-title":"Lancet Neurol"},{"key":"538_CR93","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S1059-1311(03)00096-7","volume":"12","author":"GL Wagner","year":"2003","unstructured":"Wagner GL, Wilms EB, van Donselaar CA, Vecht CJ (2003) Levetiracetam: preliminary experience in patients with primary brain tumours. Seizure 12:585\u2013586","journal-title":"Seizure"},{"key":"538_CR94","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1528-1157.1996.tb00519.x","volume":"37","author":"MM Ward","year":"1996","unstructured":"Ward MM, Barbaro NM, Laxer KD, Rampil IJ (1996) Preoperative valproate administration does not increase blood loss during temporal lobectomy. Epilepsia 37:98\u2013101","journal-title":"Epilepsia"},{"key":"538_CR95","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1212\/WNL.0b013e31822f02e1","volume":"77","author":"M Weller","year":"2011","unstructured":"Weller M, Gorlia T, Cairncross JG et al (2011) Prolonged survival with valproic acid use in the EORTC\/NCIC temozolomide trial for glioblastoma. Neurology 77:1156\u20131164","journal-title":"Neurology"},{"key":"538_CR96","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1159\/000086375","volume":"28","author":"W Wick","year":"2005","unstructured":"Wick W, Menna O, Meisner C et al (2005) Pharmacotherapy of epileptic seizures in glioma patients: who, when, why and how long? Onkologie 28:391\u2013396","journal-title":"Onkologie"},{"key":"538_CR97","first-page":"211","volume":"200155","author":"H-G Wieser","year":"2001","unstructured":"Wieser H-G, H\u00e4ne A (2001) Antiepileptic drug treatment before and after selective amygdalohippocampectomy. Epil Res 200155:211\u2013223","journal-title":"Epil Res"},{"key":"538_CR98","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1212\/WNL.0b013e318266fa89","volume":"79","author":"TI Yuen","year":"2012","unstructured":"Yuen TI, Morokoff AP, Bjorksten A et al (2012) Glutamate is associated with a higher risk of seizures in patients with gliomas. Neurology 79:883\u2013889","journal-title":"Neurology"},{"key":"538_CR99","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1212\/01.WNL.0000079374.78589.1B","volume":"61","author":"MM Zaatreh","year":"2003","unstructured":"Zaatreh MM, Firlik KS, Spencer DD, Spencer SS (2003) Temporal lobe tumoral epilepsy. Characteristics and predictors of surgical outcome. Neurology 61:636\u2013641","journal-title":"Neurology"},{"key":"538_CR100","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/00006123-199708000-00008","volume":"41","author":"J Zentner","year":"1997","unstructured":"Zentner J, Hufnagel A, Wolf KK et al (1997) Surgical treatment of neoplasms associated with medically intractable epilepsy. Neurosurgery 41:378\u2013387","journal-title":"Neurosurgery"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-014-0538-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10143-014-0538-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-014-0538-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T16:23:41Z","timestamp":1565367821000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10143-014-0538-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,24]]},"references-count":100,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["538"],"URL":"https:\/\/doi.org\/10.1007\/s10143-014-0538-6","relation":{},"ISSN":["0344-5607","1437-2320"],"issn-type":[{"value":"0344-5607","type":"print"},{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,24]]}}}